IMAGING DIAGNOSTIC SYSTEMS, INC.: 10-K filed 2024-09-30

Name: IMAGING DIAGNOSTIC SYSTEMS, INC.: 10-K filed 2024-09-30
Creator: IMAGING DIAGNOSTIC SYSTEMS, INC.

What IMAGING DIAGNOSTIC SYSTEMS, INC. reported in its annual report filed 2024-09-30 (fiscal FY 2024): 26 published measures, 49 facts as tagged in accession 0001213900-24-083313.

This filing

Form: 10-K (annual report)
Filed: 2024-09-30
Fiscal period: fiscal FY 2024
Accession: 0001213900-24-083313 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IMAGING DIAGNOSTIC SYSTEMS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2024-06-30	241	USD
At 2023-06-30	21,751	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2024-06-30	2,183,639	USD
At 2023-06-30	2,096,667	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2024-06-30	-2,653,361	USD
At 2023-06-30	-2,526,855	USD
At 2022-06-30	-2,246,879	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	-158,625	USD	366
2022-07-01 to 2023-06-30	-372,818	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	-15,225	USD	366
2022-07-01 to 2023-06-30	-88,229	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2022-07-01 to 2023-06-30	10,610	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	14,203	USD	366
2022-07-01 to 2023-06-30	88,704	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2024-06-30	-136,050,463	USD
At 2023-06-30	-135,873,814	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	123,156,941	shares	366
2022-07-01 to 2023-06-30	123,156,941	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	123,156,941	shares	366
2022-07-01 to 2023-06-30	123,156,941	shares	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	-76,662	USD	366
2022-07-01 to 2023-06-30	-291,079	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2024-06-30	241	USD
At 2023-06-30	21,751	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2024-06-30	2,183,639	USD
At 2023-06-30	2,096,667	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2024-06-30	1,000,077	USD
At 2023-06-30	932,723	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	76,662	USD	366
2022-07-01 to 2023-06-30	301,689	USD	365

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2022-07-01 to 2023-06-30	10,610	USD	365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2022-07-01 to 2023-06-30	91	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2024-06-30	123,156,941	shares
At 2023-06-30	123,156,941	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2024-06-30	66	USD
At 2023-06-30	1,088	USD
At 2022-06-30	613	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2023-06-30	37,903	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2023-06-30	37,903	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	-176,649	USD	366
2022-07-01 to 2023-06-30	-390,818	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	4,699	USD	366
2022-07-01 to 2023-06-30	87,892	USD	365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	0	USD	366
2022-07-01 to 2023-06-30	0	USD	365

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	81,963	USD	366
2022-07-01 to 2023-06-30	81,739	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2023-07-01 to 2024-06-30	-81,963	USD	366
2022-07-01 to 2023-06-30	-81,739	USD	365

Inspect the source

Entity: IMAGING DIAGNOSTIC SYSTEMS, INC. / CIK 0000790652
Captured: 2026-09-21T17:16:58.404Z
SEC response SHA-256: 162e8586bc60f736623638d621f47cee4688f27408299480b3b1b569a1861b55

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000790652.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))